Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Jan Moritz Middeke

12PUBLICATIONS

82CO-AUTHORS

Medical mycologyRheumatology and arthritisPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Oct 28, 2025

Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.

Marius Bill, Jan-Niklas Eckardt, Konstanze Döhner

|Jun 25, 2025

Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study.

Robert Zeiser, Domenico Russo, Ron Ram

|May 08, 2025

Age-stratified machine learning identifies divergent prognostic significance of molecular alterations in AML.

Jan-Niklas Eckardt, Waldemar Hahn, Rhonda E Ries

|Apr 08, 2025

Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients.

Christina Rautenberg, Jan Moritz Middeke, Christoph Röllig

|Sep 16, 2024

Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia.

Christoph Röllig, Björn Steffen, Christoph Schliemann

|May 26, 2023

UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome.

Julia-Annabell Georgi, Sebastian Stasik, Jan-Niklas Eckardt

Pageof 2

Frequent Collaborators

9 joint publications

Johannes Schetelig

6 joint publications

Christoph Röllig

6 joint publications

Stefan W Krause

5 joint publications

Christoph Schliemann

5 joint publications

Jan-Niklas Eckardt

5 joint publications

Christian Thiede

4 joint publications

Andreas Burchert

4 joint publications

Sebastian Stasik

4 joint publications

Claudia D Baldus

3 joint publications

Katja Sockel

Frequent Collaborators

9 joint publications

Johannes Schetelig

6 joint publications

Christoph Röllig

6 joint publications

Stefan W Krause

5 joint publications

Christoph Schliemann

Top Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on : Jun 06, 2025

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on : Dec 07, 2014

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on : Nov 10, 2023

See more related videos

Top Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on : Jun 06, 2025

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on : Dec 07, 2014

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on : Nov 10, 2023

See more related videos